Tandem Diabetes Care (TNDM) Restructuring Costs (2025)
Tandem Diabetes Care's (TNDM) quarterly Restructuring Costs came in at $20.0 million in Q2 2025.
Tandem Diabetes Care (TNDM) Restructuring Costs (2025) Analysis & Trends
Tandem Diabetes Care (TNDM) has 1 years of Restructuring Costs data on file, last reported at $20.0 million in Q2 2025.
- Quarterly Restructuring Costs changed N/A year-over-year to $20.0 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $20.0 million (changed N/A YoY) and the FY2025 annual result came in at $20.0 million, changed N/A from the prior year.
- Restructuring Costs steadied at $20.0 million in Q2 2025.
- In the past five years, Restructuring Costs ranged from a high of $20.0 million in Q2 2025 to a low of $20.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.59 Bn | 1.13 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 19.95 Mn |